erythrosine has been researched along with Ovarian Neoplasms in 25 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluorescein-labeled dextrans (FITC-D) from 3 to 5000 kDa (Stokes' radii from 1 to 40 nm) were used to study influx from the plasma into the peritoneum and efflux from the peritoneal cavity into the plasma in normal and ascites tumor-bearing mice and in mice whose peritoneal vessels had been rendered hyperpermeable by serotonin." | 3.67 | Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. ( Dvorak, HF; Herzberg, KT; Masse, EM; Nagy, JA; Zientara, GP, 1989) |
| "Cisplatin resistance in ovarian cancer remains a complex problem as tumors frequently develop resistance against drugs, a mechanism sometimes mediated by ATP-Binding Cassette transporters." | 1.48 | Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition. ( Andrieu, T; Boumendjel, A; Comsa, E; Falson, P; Loghin, F; Nguyen, KA; Peuchmaur, M, 2018) |
| "The nude mouse ovarian cancer model was established." | 1.42 | OSTP as a novel peptide specifically targeting human ovarian cancer. ( He, X; Liang, X; Liu, X; Tang, Z; Yang, C, 2015) |
| "Eight ovarian cancer cell lines were tested (SKOV3, CAOV3, OVCAR3, OVCAR10, A2780, CP70, C30, and C200) and showed IC50s for EGCG at the micromolar range, including ones that are resistant to the chemotherapeutic drug cisplatin." | 1.33 | Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. ( Chan, MM; Fong, D; Soprano, KJ; Weinstein, K, 2006) |
| "We used IGROV1 ovarian cancer cells loaded with CFSE at the time of seeding; 24 h later cells were treated with an anticancer drug (topotecan)." | 1.32 | Heterogeneous cell response to topotecan in a CFSE-based proliferation test. ( Lupi, M; Matera, G; Ubezio, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotz, S | 1 |
| Kullmann, M | 1 |
| Kalayda, GV | 1 |
| Dyballa-Rukes, N | 1 |
| Jaehde, U | 1 |
| Metzger, S | 1 |
| Comsa, E | 1 |
| Nguyen, KA | 1 |
| Loghin, F | 1 |
| Boumendjel, A | 1 |
| Peuchmaur, M | 1 |
| Andrieu, T | 1 |
| Falson, P | 1 |
| Oh, D | 1 |
| Nasrolahi Shirazi, A | 1 |
| Northup, K | 1 |
| Sullivan, B | 1 |
| Tiwari, RK | 1 |
| Bisoffi, M | 1 |
| Parang, K | 1 |
| Yang, C | 1 |
| He, X | 1 |
| Liu, X | 1 |
| Tang, Z | 1 |
| Liang, X | 1 |
| Kasaian, J | 1 |
| Mosaffa, F | 1 |
| Behravan, J | 1 |
| Masullo, M | 1 |
| Piacente, S | 1 |
| Iranshahi, M | 1 |
| Dong, X | 1 |
| Mattingly, CA | 1 |
| Tseng, MT | 1 |
| Cho, MJ | 1 |
| Liu, Y | 1 |
| Adams, VR | 1 |
| Mumper, RJ | 1 |
| Duan, Z | 1 |
| Choy, E | 1 |
| Hornicek, FJ | 1 |
| Xiang, J | 1 |
| Xia, X | 1 |
| Jiang, Y | 1 |
| Leung, AW | 1 |
| Wang, X | 1 |
| Xu, J | 1 |
| Wang, P | 1 |
| Yu, H | 1 |
| Bai, D | 1 |
| Xu, C | 1 |
| Zhao, M | 1 |
| Bai, L | 1 |
| Toki, A | 1 |
| Hasegawa, R | 1 |
| Sakai, J | 1 |
| Hasegawa, T | 1 |
| Ogura, H | 1 |
| Kataoka, T | 1 |
| Bai, Y | 1 |
| Ando, M | 2 |
| Hirose, K | 1 |
| Escrevente, C | 1 |
| Keller, S | 1 |
| Altevogt, P | 1 |
| Costa, J | 1 |
| Jovelet, C | 1 |
| Bénard, J | 1 |
| Forestier, F | 1 |
| Farinotti, R | 1 |
| Bidart, JM | 1 |
| Gil, S | 1 |
| He, J | 1 |
| Xu, Q | 1 |
| Jing, Y | 1 |
| Agani, F | 1 |
| Qian, X | 1 |
| Carpenter, R | 1 |
| Li, Q | 1 |
| Wang, XR | 1 |
| Peiper, SS | 1 |
| Lu, Z | 1 |
| Liu, LZ | 1 |
| Jiang, BH | 1 |
| Jakubikova, J | 1 |
| Duraj, J | 1 |
| Hunakova, L | 1 |
| Chorvath, B | 1 |
| Sedlak, J | 1 |
| Park, LO | 1 |
| Yoon, JH | 1 |
| Kim, JD | 1 |
| Seo, JT | 1 |
| Bae, SN | 1 |
| Matera, G | 1 |
| Lupi, M | 1 |
| Ubezio, P | 1 |
| Chan, MM | 1 |
| Soprano, KJ | 1 |
| Weinstein, K | 1 |
| Fong, D | 1 |
| Bracher, M | 1 |
| Gould, HJ | 1 |
| Sutton, BJ | 1 |
| Dombrowicz, D | 1 |
| Karagiannis, SN | 1 |
| Pritchard, JA | 1 |
| Sutherland, WH | 1 |
| Siddall, JE | 1 |
| Bater, AJ | 1 |
| Kerby, IJ | 1 |
| Deeley, TJ | 1 |
| Pierelli, L | 1 |
| Scambia, G | 1 |
| Fattorossi, A | 1 |
| Bonanno, G | 1 |
| Battaglia, A | 1 |
| Rumi, C | 1 |
| Marone, M | 1 |
| Mozzetti, S | 1 |
| Rutella, S | 1 |
| Menichella, G | 1 |
| Romeo, V | 1 |
| Mancuso, S | 1 |
| Leone, G | 1 |
| Nagy, JA | 1 |
| Herzberg, KT | 1 |
| Masse, EM | 1 |
| Zientara, GP | 1 |
| Dvorak, HF | 1 |
| Heuser, LS | 1 |
| Miller, FN | 1 |
| Gilley-Pietsch, C | 1 |
| Masood, S | 1 |
| Matsumoto, J | 1 |
| Tenzaki, T | 1 |
| Ishiguro, T | 1 |
| Hulett, HR | 1 |
| Bonner, WA | 1 |
| Barrett, J | 1 |
| Herzenberg, LA | 1 |
| Nagel, GA | 1 |
25 other studies available for erythrosine and Ovarian Neoplasms
| Article | Year |
|---|---|
Optimized two-dimensional gel electrophoresis in an alkaline pH range improves the identification of intracellular CFDA-cisplatin-protein adducts in ovarian cancer cells.
Topics: Cell Line, Tumor; Cisplatin; Electrophoresis, Gel, Two-Dimensional; Female; Fluoresceins; Humans; Hy | 2018 |
Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition.
Topics: Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neo | 2018 |
Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization.
Topics: Acylation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell-Penetrating Peptides; Cyclizati | 2014 |
OSTP as a novel peptide specifically targeting human ovarian cancer.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Drug Delivery Systems; Female; Fluoresceins; Humans; Mice; | 2015 |
Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cisplatin; Coumarins; Drug Resistance, Multiple | 2016 |
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
Topics: Adenosine Triphosphate; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2009 |
NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Mem | 2009 |
Apoptosis of ovarian cancer cells induced by methylene blue-mediated sonodynamic action.
Topics: Analysis of Variance; Apoptosis; Female; Flow Cytometry; Fluoresceins; Humans; Methylene Blue; Micro | 2011 |
The structure of a new cardenolide diglycoside and the biological activities of eleven cardenolide diglycosides from Nerium oleander.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cardenolides; Cell Line, Tumor; Drug Re | 2011 |
Interaction and uptake of exosomes by ovarian cancer cells.
Topics: Biological Transport; Carcinoma, Ovarian Epithelial; Cells, Cultured; Endocytosis; Exosomes; Female; | 2011 |
Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Tra | 2012 |
Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation.
Topics: Allantois; Animals; Cell Line, Tumor; Chickens; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine | 2012 |
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biologica | 2002 |
Necrotic cell death of ovarian adenocarcinoma caused by seminal plasma.
Topics: Acridine Orange; Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; DNA Fragmentation; Epithe | 2004 |
Heterogeneous cell response to topotecan in a CFSE-based proliferation test.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Evaluation Studies as Topic; Female; Fl | 2004 |
Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2006 |
Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody-Dependent Cell Cytotoxicity; Antigens, Neopla | 2007 |
Fluorescent probes for the detection of malignant disease.
Topics: 1-Naphthylamine; Carcinoma; Cell Separation; Female; Flow Cytometry; Fluorescein; Fluoresceins; Huma | 1983 |
Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors.
Topics: Antigens, CD; Antigens, CD34; Cell Cycle; Cell Division; Cytokines; Endoglin; Female; Fluoresceins; | 1998 |
Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.
Topics: Adenocarcinoma; Animals; Ascites; Biological Transport; Breast Neoplasms; Capillary Permeability; De | 1989 |
Protein leak from normal vasculature due to human malignant ascites.
Topics: Adenocarcinoma; Animals; Ascites; Ascitic Fluid; Blood Proteins; Capillary Permeability; Edetic Acid | 1988 |
The potential value of imprint cytology in cytochemical localization of steroid hormone receptors in ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma; Cytological Techniques; Endometr | 1988 |
[Clinical evaluation of fluorescein polarization of peripheral lymphocytes (SCM test) in the diagnosis of cancer].
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluoresceins; Humans; Lymphocyte Activation | 1985 |
Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence.
Topics: Animals; Automation; Cell Biology; Cricetinae; Culture Techniques; Female; Fluoresceins; Fluorescenc | 1969 |
[Immunosuppression: a paraneoplastic syndrome].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Bronchial Neoplasms; Culture Techniques; Cyclophosphamide; | 1971 |